ThinkEquity Initiates Coverage On BioVie With Buy Rating, Announces Price Target of $3
ThinkEquity Initiates Coverage On BioVie With Buy Rating, Announces Price Target of $3
ThinkEquity開啓了BioVie的買入評級,並宣佈目標價爲3美元
ThinkEquity analyst Ashok Kumar initiates coverage on BioVie (NASDAQ:BIVI) with a Buy rating and announces Price Target of $3.
ThinkEquity分析師Ashok Kumar開始對BioVie (納斯達克股票代碼:BIVI)進行買入評級,並宣佈目標價爲3美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。